ATNC05

· Allodynic Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ATNC05, covering 2014-03-13 to 2014-03-13. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of ATNC05 in Treatment of Atypical Facial Pain [Phase 2, Phase 3]